Concourse Financial Group Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Concourse Financial Group Securities's IHE Position: Q1 2025 in Review
Concourse Financial Group Securities sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2025, closing a stake of 168 shares — an estimated $11.2K sold.
Concourse Financial Group Securities first reported a position in IHE in Q3 2018 and held it in 26 quarters. The position peaked at $3.8M in Q3 2020. 149 funds tracked by Wall St. Rank hold IHE as of Q1 2025.
- Concourse Financial Group Securities reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
- Concourse Financial Group Securities sold 168 iShares US Pharmaceuticals ETF shares in Q1 2025, an estimated $11.2K.
- Concourse Financial Group Securities first reported a position in iShares US Pharmaceuticals ETF in Q3 2018 and held it in 26 quarters.
- Concourse Financial Group Securities's iShares US Pharmaceuticals ETF position peaked at $3.8M in Q3 2020.
- 149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2025.
Based on Concourse Financial Group Securities's 13F filing for Q1 2025.